acq	eli lilly lly sell elizabeth arden unit eli lilly and board decided sell elizabeth arden inc wholly owned subsidiary that manufactures and markets cosmetics and fine fragrance products business had sales mln dlrs acquired had sales last year mln dlrs pct had operating profits mln dlrs lilly retained morgan stanley and evaluate offers lilly expects use tax proceeds sale cosmetics business for general corporate purposes including repurchase time time common stock warrants open market statement lilly chairman richard wood this strategic decision reached basis belief that future corporation resources including research activities focused business high technology life sciences orientation InformationRetrieval.reuter